Illumina slashes costs by $100 million after China bans its sequencers. The company lowers its 2025 EPS outlook and aims for ...
and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. Receive News & Ratings for Illumina Daily - Enter your email address below to ...
Mammalian genomes are organized by multi-level folding, yet how this organization contributes to cell type-specific transcription remain unclear. We uncovered that the nuclear protein SATB1 ...
Illumina, Inc. (NASDAQ ... X single-flow-cell system alongside a cutting-edge software upgrade and new kits.
Setting the standard through dynamic genomic technology platform, improving patient outcomes AURORA, Colo., /PRNewswire/ -- ...
ANZA BORREGO Events at desert state park The Anza-Borrego Foundation hosts a number of activities this week at the Anza-Borrego Desert State Park, including a Guided Driving Tour from 8:30 a.m. to ...
Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...
Illumina (NASDAQ:ILMN – Free Report) had its target price decreased by Robert W. Baird from $127.00 to $90.00 in a research report report published on Wednesday morning,Benzinga reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results